3 Myths About Marijuana Stocks

What do Hercules, Thor, centaurs, and marijuana stocks have in common? They're all the subjects of myths. Most myths have at least a little bit of truth interspersed with a lot that is false. That's the case with these three myths about marijuana stocks that some might mistakenly believe.

Myth No. 1: All marijuana stocks are hot.

Marijuana stocks in general are hot right now. It's wrong, though, to think that all marijuana stocks are performing well. They're not.

One of the marijuana stocks with the biggest valuations is Insys Therapeutics (NASDAQ: INSY). Insys trades at a market cap of roughly $650 million and won U.S. regulatory approval for its first cannabinoid drug, Syndros. You might think the biotech would be a big winner. Nope. Insys lost around two-thirds of its value in 2016.

Although approval of Syndros was a big positive for Insys, the drug still awaits scheduling by...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.